Skip to main content
Figure 6 | BMC Bioinformatics

Figure 6

From: PREDIVAC: CD4+ T-cell epitope prediction for vaccine design that covers 95% of HLA class II DR protein diversity

Figure 6

Distribution of the percentages corresponding to the rankings associated with all the CD4+ T-cell immunodominant epitopes in the context of their corresponding source proteins, for four pan-specific methods. Predivac, TEPITOPEpan, NetMHCIIPan-2.0 and MutiRTA are compared. From the bottom up, the first stack represents the percentage of immunodominant epitope scores in 0-1% of top scores; second stack: 1-3%; third stack: 3-5%; forth stack: remaining 5-100%.

Back to article page